Sherry T. Shu

974 citations
34 papers · 743 indexed · h-index 18
Topics
HIV Research and Treatment (11 papers)HIV/AIDS drug development and treatment (7 papers)T-cell and Retrovirus Studies (5 papers)
Journals
Journal of Biological ChemistrySHILAP Revista de lepidopterologíaCancer Research
Partner nations
United StatesFranceEgypt

In The Last Decade

Sherry T. Shu

33 papers receiving 734 citations

Peers

Sherry T. Shu
Comparison fields: 5 of 81
  • Molecular Biology 342
  • Oncology 233
  • Immunology 153
  • Virology 124
  • Pulmonary and Respiratory Medicine 113
Replace Peter DeLong with:
Peter DeLong United States
Joseph C. Beyer United States
Kohei Tada Japan
Robert R. Conroy United States
Naomi Taylor France
Line Saffar France
Flavia Borellini United States
J. J. Rinehart United States
Anthony J. Scarzello United States
Joseph Bekisz United States
Sherry T. Shu relative to Peter DeLong United States Peter DeLong's profile →
Citations per field
00.5×5.9×
Peter DeLong · 1×
Citations per year

Countries citing papers authored by Sherry T. Shu

Since Specialization
Citations

This map shows the geographic impact of Sherry T. Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherry T. Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherry T. Shu more than expected).

Fields of papers citing papers by Sherry T. Shu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherry T. Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherry T. Shu. The network helps show where Sherry T. Shu may publish in the future.

Co-authorship network of co-authors of Sherry T. Shu

This figure shows the co-authorship network connecting the top 25 collaborators of Sherry T. Shu. A scholar is included among the top collaborators of Sherry T. Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherry T. Shu. Sherry T. Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 17
3 5
4 2
5 3
6 9
7 15
8 15
9 45
10 20
11 45
12 7
13 31
14 25
15 103
16 37
17 28
18
Conjugated linoleic acid (CLA) modulates prostaglandin E2 (PGE2) signaling in canine mammary cells.
18
19
Anti-angiogenesis effects of conjugated linoleic acid in human breast cancer cell line MCF-7
2
20 16

About Sherry T. Shu

Sherry T. Shu is a scholar working on Virology, Immunology and Infectious Diseases, having authored 34 papers that have together received 743 indexed citations. Recurring topics across this work include HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (7 papers) and T-cell and Retrovirus Studies (5 papers). The work is most often cited by research in Virology (124 citations), Oncology (233 citations) and Immunology (153 citations). Sherry T. Shu has collaborated with scholars based in United States, France and Egypt. Frequent co-authors include Thomas J. Rosol, Thomas E. Smithgall, Nanda K. Thudi, Jillian L. Werbeck, Chelsea K. Martin, Wessel P. Dirksen, Lori A. Emert‐Sedlak, Haibin Shi, Laurie K. McCauley and Young C. Lin. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026